Dr. James J. Collins, A Pioneer In Synthetic Biology, Joins The Scientific Advisory Board Of Agilis Biotherapeutics
3/5/2014 9:28:47 AM
Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today Professor James J. Collins, Ph.D., a pioneer in the field of synthetic biology, has joined its Scientific Advisory Board. Dr. Collins' scientific achievements and accomplishments have been recognized by numerous organizations for his groundbreaking work and fundamental discoveries in the field of synthetic biology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by